| Product Code: ETC7487376 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Hong Kong continued to see significant import shipments of quinolones, with top exporting countries being China, India, USA, Italy, and Mexico. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. The compound annual growth rate (CAGR) from 2020 to 2024 was impressive at 31.88%, demonstrating strong demand for quinolones in Hong Kong. Furthermore, the growth rate from 2023 to 2024 stood at 8.17%, suggesting a continued upward trend in import volumes. This data underscores the importance of these key exporting countries in meeting Hong Kong`s quinolone needs.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hong Kong Quinolones Market Overview |
3.1 Hong Kong Country Macro Economic Indicators |
3.2 Hong Kong Quinolones Market Revenues & Volume, 2021 & 2031F |
3.3 Hong Kong Quinolones Market - Industry Life Cycle |
3.4 Hong Kong Quinolones Market - Porter's Five Forces |
3.5 Hong Kong Quinolones Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Hong Kong Quinolones Market Revenues & Volume Share, By Pathogen Type, 2021 & 2031F |
3.7 Hong Kong Quinolones Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Hong Kong Quinolones Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Hong Kong Quinolones Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Hong Kong Quinolones Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Hong Kong Quinolones Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Hong Kong |
4.2.2 Growing awareness about the effectiveness of quinolones in treating infections |
4.2.3 Rising healthcare expenditure and infrastructure development in Hong Kong |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of quinolone drugs |
4.3.2 Concerns regarding antibiotic resistance and side effects associated with quinolones |
5 Hong Kong Quinolones Market Trends |
6 Hong Kong Quinolones Market, By Types |
6.1 Hong Kong Quinolones Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Hong Kong Quinolones Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Hong Kong Quinolones Market Revenues & Volume, By Urinary Tract Infection, 2021- 2031F |
6.1.4 Hong Kong Quinolones Market Revenues & Volume, By Intra-Abdominal Infections, 2021- 2031F |
6.1.5 Hong Kong Quinolones Market Revenues & Volume, By Blood Stream Infections, 2021- 2031F |
6.1.6 Hong Kong Quinolones Market Revenues & Volume, By Clostridium Difficile Infections, 2021- 2031F |
6.2 Hong Kong Quinolones Market, By Pathogen Type |
6.2.1 Overview and Analysis |
6.2.2 Hong Kong Quinolones Market Revenues & Volume, By Gram-Positive Pathogen, 2021- 2031F |
6.2.3 Hong Kong Quinolones Market Revenues & Volume, By Gram-Negative Pathogen, 2021- 2031F |
6.3 Hong Kong Quinolones Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Hong Kong Quinolones Market Revenues & Volume, By Lomefloxacin, 2021- 2031F |
6.3.3 Hong Kong Quinolones Market Revenues & Volume, By Gatifloxacin, 2021- 2031F |
6.3.4 Hong Kong Quinolones Market Revenues & Volume, By Norfloxacin, 2021- 2031F |
6.3.5 Hong Kong Quinolones Market Revenues & Volume, By Moxifloxacin, 2021- 2031F |
6.3.6 Hong Kong Quinolones Market Revenues & Volume, By Ciprofloxacin, 2021- 2031F |
6.4 Hong Kong Quinolones Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Hong Kong Quinolones Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Hong Kong Quinolones Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5 Hong Kong Quinolones Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Hong Kong Quinolones Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Hong Kong Quinolones Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Hong Kong Quinolones Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6 Hong Kong Quinolones Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Hong Kong Quinolones Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Hong Kong Quinolones Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 Hong Kong Quinolones Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Hong Kong Quinolones Market Import-Export Trade Statistics |
7.1 Hong Kong Quinolones Market Export to Major Countries |
7.2 Hong Kong Quinolones Market Imports from Major Countries |
8 Hong Kong Quinolones Market Key Performance Indicators |
8.1 Prescription rate of quinolones by healthcare providers in Hong Kong |
8.2 Patient adherence to quinolone treatment regimens |
8.3 Number of new quinolone drug approvals by regulatory authorities |
9 Hong Kong Quinolones Market - Opportunity Assessment |
9.1 Hong Kong Quinolones Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Hong Kong Quinolones Market Opportunity Assessment, By Pathogen Type, 2021 & 2031F |
9.3 Hong Kong Quinolones Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Hong Kong Quinolones Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Hong Kong Quinolones Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 Hong Kong Quinolones Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Hong Kong Quinolones Market - Competitive Landscape |
10.1 Hong Kong Quinolones Market Revenue Share, By Companies, 2024 |
10.2 Hong Kong Quinolones Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here